Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience.
雾化干扰素-β-1b治疗COVID-19的理论依据——文献综述和个人初步经验
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2020.592543
Mary Aurélien, Hénaut Lucie, Macq Pierre Yves, Badoux Louise, Cappe Arnaud, Porée Thierry, Eckes Myriam, Dupont Hervé, Brazier Michel
